5613423 TREATMENT OF ERYTHROID PRECURSOR CELLS FROM β-THALASSEMIC PATIENTS WITH ISOXAZOLE DERIVATIVES: POTENT INDUCTION OF FETAL HEMOGLOBIN

5613423 TREATMENT OF ERYTHROID PRECURSOR CELLS FROM β-THALASSEMIC PATIENTS WITH ISOXAZOLE DERIVATIVES: POTENT INDUCTION OF FETAL HEMOGLOBIN

Bibliographic Details
Main Authors:	C.Z. Cristina Zuccato, L.C.C. Lucia Carmela Cosenza, G.S. Gianni Sacchetti, R.R. Riccardo Rondanin, D.S. Daniele Simoni, M.P. Marco Prosdocimi, M.L.P. Lipucci di Paola, A.F. Alessia Finotti, R.G. Roberto Gambari, I.L. Ilaria Lampronti
Format:	Article
Language:	English
Published:	Wiley 2023-04-01
Series:	HemaSphere
Online Access:	http://journals.lww.com/10.1097/01.HS9.0000928252.78758.54

Similar Items

New Synthetic Isoxazole Derivatives Acting as Potent Inducers of Fetal Hemoglobin in Erythroid Precursor Cells Isolated from β-Thalassemic Patients
by: Cristina Zuccato, et al.
Published: (2023-12-01)

5613417 CO-TREATMENT OF ERYTHROID CELLS ISOLATED FROM Β039-THALASSEMIA PATIENTS WITH CRISPR-CAS9 GENE EDITING AND FETAL HEMOGLOBIN INDUCTION
by: M.L.P. Lipucci di Paola, et al.
Published: (2023-04-01)

5613398 A DRUG REPOSITIONING PROJECT FOR Β-THALASSEMIA: SIROLIMUS AND CINCHONA ALKALOIDS
by: M.L.P. Michele Lipucci Di Paola, et al.
Published: (2023-04-01)

A Rational Approach to Drug Repositioning in β-thalassemia: Induction of Fetal Hemoglobin by Established Drugs [version 3; peer review: 2 approved]
by: Alessia Finotti, et al.
Published: (2022-08-01)

Efficient CRISPR-Cas9-based genome editing of β-globin gene on erythroid cells from homozygous β039-thalassemia patients
by: Lucia Carmela Cosenza, et al.
Published: (2021-06-01)

Increase of microRNA-210, decrease of raptor gene expression and alteration of mammalian target of rapamycin regulated proteins following mithramycin treatment of human erythroid cells.
by: Nicoletta Bianchi, et al.
Published: (2015-01-01)

The Long Scientific Journey of Sirolimus (Rapamycin): From the Soil of Easter Island (Rapa Nui) to Applied Research and Clinical Trials on β-Thalassemia and Other Hemoglobinopathies
by: Roberto Gambari, et al.
Published: (2023-09-01)

Imbalanced globin chain synthesis determines erythroid cell pathology in thalassemic mice
by: Kanitta Srinoun, et al.
Published: (2009-09-01)

Combined approaches for increasing fetal hemoglobin (HbF) and de novo production of adult hemoglobin (HbA) in erythroid cells from β-thalassemia patients: treatment with HbF inducers and CRISPR-Cas9 based genome editing
by: Alessia Finotti, et al.
Published: (2023-07-01)

miR-214 aggravates oxidative stress in thalassemic erythroid cells by targeting ATF4
by: Tipparat Penglong, et al.
Published: (2024-01-01)

Effects of Sirolimus Treatment on Fetal Hemoglobin Production and Response to SARS-CoV-2 Vaccination: A Case Report Study
by: Maria Rita Gamberini, et al.
Published: (2023-07-01)

Hydroxyurea responsiveness in β-thalassemic patients is determined by the stress response adaptation of erythroid progenitors and their differentiation propensity
by: Farzin Pourfarzad, et al.
Published: (2013-05-01)

Resveratrol accelerates erythroid maturation by activation of FoxO3 and ameliorates anemia in beta-thalassemic mice
by: Sara Santos Franco, et al.
Published: (2014-02-01)

Recent trends in the gene therapy of β-thalassemia
by: Finotti A, et al.
Published: (2015-02-01)

Teaching during COVID-19 pandemic in practical laboratory classes of applied biochemistry and pharmacology: A validated fast and simple protocol for detection of SARS-CoV-2 Spike sequences.
by: Jessica Gasparello, et al.
Published: (2022-01-01)

P1458: MITAPIVAT AMELIORATES IN VITRO HUMAN Β THALASSEMIC ERYTHROID MATURATION INDEX AND MODULATES THE EXPRESSION OF THE CYTOPROTECTOR PEROXIREDOXIN-2.
by: Alessandro Matte’, et al.
Published: (2023-08-01)

HFE gene mutations in Brazilian thalassemic patients
by: T.M. Oliveira, et al.
Published: (2006-12-01)

Expression of γ-globin genes in β-thalassemia patients treated with sirolimus: results from a pilot clinical trial (Sirthalaclin)
by: Cristina Zuccato, et al.
Published: (2022-06-01)

Interplay of TLR4 and SARS-CoV-2: Possible Involvement of microRNAs [Letter]
by: Gambari R, et al.
Published: (2024-11-01)

Role of Cystic Fibrosis Bronchial Epithelium in Neutrophil Chemotaxis
by: Giulio Cabrini, et al.
Published: (2020-08-01)

Iron overload in Brazilian thalassemic patients
by: Reijane Alves de Assis, et al.
Published: (2011-06-01)

Iron overload in Brazilian thalassemic patients
by: Reijane Alves de Assis, et al.
Published: (2011-06-01)

Fertility assessment in thalassemic men
by: Shahla Ansari, et al.
Published: (2017-07-01)

Coagulation defects in thalassemic patients
by: Mostafa M. Abosdera, et al.
Published: (2017-10-01)

Synthesis and Structure of Unsymmetrical Anthracenyl-Isoxazole Antitumor Agents Via the Diastereoselective Bromination of 3-(9′-Anthryl)-Isoxazole Esters
by: Michael J. Campbell, et al.
Published: (2024-03-01)

Evaluation of salivary immunoglobulin A level in thalassemic patients with periodontitis in comparison with thalassemic patients with healthy periodontium
by: Mohadeseh Arabsolghar, et al.
Published: (2017-01-01)

Portal Vein Thrombosis after Splenectomy in Thalassemic Patients
by: AA Darzi, et al.
Published: (2013-03-01)

Challenges of Iron Chelation in Thalassemic Children
by: Alkistis Adramerina, et al.
Published: (2024-02-01)

Contrast sensitivity in β-thalassemic patients
by: Tamer H El-Sersy, et al.
Published: (2015-01-01)

Affective control and life satisfaction in thalassemics
by: Carmela Mento, et al.
Published: (2015-01-01)

Affective control and life satisfaction in thalassemics
by: Carmela Mento, et al.
Published: (2015-01-01)

Evaluation of Leptin Levels in Major beta-Thalassemic Patients
by: Hamid Choobineh, et al.
Published: (2009-10-01)

Evaluation of Leptin Levels in Major beta-Thalassemic Patients
by: Hamid Choobineh, et al.
Published: (2009-12-01)

Myocardial iron is strongly associated with reproductive function in beta-thalassemic women under chelation therapy
by: M. A. Castaldi, et al.
Published: (2020-02-01)

Perspectives in MicroRNA Therapeutics for Cystic Fibrosis
by: Alessia Finotti, et al.
Published: (2025-01-01)

Therapeutic Relevance of Inducing Autophagy in β-Thalassemia
by: Roberto Gambari, et al.
Published: (2024-05-01)

MicroRNAs in erythroid and megakaryocytic differentiation and megakaryocyte–erythroid progenitor lineage commitment
by: Zhang, L., et al.
Published: (2014)

Isoxazole Derivatives as Regulators of Immune Functions
by: Michał Zimecki, et al.
Published: (2018-10-01)

Synthesis of Some Fused Pyrazoles and Isoxazoles
by: Dandu Bhaskar Reddy, et al.
Published: (2000-12-01)

The Cystic Fibrosis Transmembrane Conductance Regulator Gene (CFTR) Is under Post-Transcriptional Control of microRNAs: Analysis of the Effects of agomiRNAs Mimicking miR-145-5p, miR-101-3p, and miR-335-5p
by: Chiara Papi, et al.
Published: (2023-04-01)